GAS6
Growth arrest-specific protein 6
Also known as: AXLLG, AXSF, DKFZp666G247, FLJ34709, GAS6_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q14393
- Gene
- GAS6
- Ensembl
- ENSG00000183087
- Chromosome
- 13
- Canonical length
- 678 aa
- Protein class
- Predicted secreted proteins
- Subcellular location
- Centriolar satellite,Cytosol
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene encodes a gamma-carboxyglutamic acid (Gla)-containing protein thought to be involved in the stimulation of cell proliferation. This gene is frequently overexpressed in many cancers and has been implicated as an adverse prognostic marker. Elevated protein levels are additionally associated with a variety of disease states, including venous thromboembolic disease, systemic lupus erythematosus, chronic renal failure, and preeclampsia. [provided by RefSeq, Aug 2014]
Canonical amino-acid sequenceUniProt
678 residues, UniProt reviewed canonical sequence.
>Q14393|GAS6
1 MAPSLSPGPA ALRRAPQLLL LLLAAECALA ALLPAREATQ FLRPRQRRAF QVFEEAKQGH
61 LERECVEELC SREEAREVFE NDPETDYFYP RYLDCINKYG SPYTKNSGFA TCVQNLPDQC
121 TPNPCDRKGT QACQDLMGNF FCLCKAGWGG RLCDKDVNEC SQENGGCLQI CHNKPGSFHC
181 SCHSGFELSS DGRTCQDIDE CADSEACGEA RCKNLPGSYS CLCDEGFAYS SQEKACRDVD
241 ECLQGRCEQV CVNSPGSYTC HCDGRGGLKL SQDMDTCEDI LPCVPFSVAK SVKSLYLGRM
301 FSGTPVIRLR FKRLQPTRLV AEFDFRTFDP EGILLFAGGH QDSTWIVLAL RAGRLELQLR
361 YNGVGRVTSS GPVINHGMWQ TISVEELARN LVIKVNRDAV MKIAVAGDLF QPERGLYHLN
421 LTVGGIPFHE KDLVQPINPR LDGCMRSWNW LNGEDTTIQE TVKVNTRMQC FSVTERGSFY
481 PGSGFAFYSL DYMRTPLDVG TESTWEVEVV AHIRPAADTG VLFALWAPDL RAVPLSVALV
541 DYHSTKKLKK QLVVLAVEHT ALALMEIKVC DGQEHVVTVS LRDGEATLEV DGTRGQSEVS
601 AAQLQERLAV LERHLRSPVL TFAGGLPDVP VTSAPVTAFY RGCMTLEVNR RLLDLDEAAY
661 KHSDITAHSC PPVEPAAALocalizationUniProt · AlphaFold · HPA
Whether an antibody against GAS6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 838 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 838 nTPM
- cervix: 195 nTPM
- endometrium: 164 nTPM
- vagina: 161 nTPM
- heart muscle: 158 nTPM
- fallopian tube: 151 nTPM
Single-cell type
- fallopian secretory cells: 501 nCPM
- alveolar cells type 1: 372 nCPM
- breast myoepithelial cells: 333 nCPM
- smooth muscle cells: 307 nCPM
- granulosa cells: 305 nCPM
- retinal horizontal cells: 248 nCPM
Immune cell
- plasmacytoid DC: 71 nTPM
- myeloid DC: 11 nTPM
- classical monocyte: 1.4 nTPM
- total PBMC: 1.4 nTPM
- intermediate monocyte: 1.1 nTPM
- non-classical monocyte: 0.3 nTPM
Brain region
- choroid plexus: 113 nTPM
- pons: 70 nTPM
- medulla oblongata: 67 nTPM
- midbrain: 66 nTPM
- hypothalamus: 61 nTPM
- thalamus: 60 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.49
- gnomAD pLI
- 0.03
- gnomAD missense Z
- 1.19
- DepMap mean gene effect
- 0
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- activation of protein kinase B activity
- animal organ regeneration
- apoptotic cell clearance
- B cell chemotaxis
- blood coagulation
- calcium ion transmembrane transport
- cell surface receptor signaling pathway
- cell-substrate adhesion
- cellular response to glucose stimulus
- cellular response to growth factor stimulus
- cellular response to interferon-alpha
- cellular response to starvation
- cellular response to vitamin K
- cellular response to xenobiotic stimulus
- dendritic cell differentiation
- enzyme-linked receptor protein signaling pathway
- extracellular matrix assembly
- fibroblast apoptotic process
- fusion of virus membrane with host plasma membrane
- hematopoietic stem cell migration to bone marrow
- myeloid cell apoptotic process
- negative regulation of apoptotic process
- negative regulation of biomineral tissue development
- negative regulation of dendritic cell apoptotic process
- negative regulation of DNA-templated transcription
- negative regulation of endothelial cell apoptotic process
- negative regulation of fibroblast apoptotic process
- negative regulation of interleukin-1 production
- negative regulation of interleukin-6 production
- negative regulation of myeloid cell apoptotic process
- negative regulation of tumor necrosis factor production
- negative regulation of tumor necrosis factor-mediated signaling pathway
- negative regulation of type II interferon production
- neuron migration
- phagocytosis
- positive regulation of cytokine-mediated signaling pathway
- positive regulation of dendritic cell chemotaxis
- positive regulation of ERK1 and ERK2 cascade
- positive regulation of fibroblast proliferation
- positive regulation of gene expression
- positive regulation of glomerular filtration
- positive regulation of natural killer cell differentiation
- positive regulation of phagocytosis
- positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- positive regulation of protein export from nucleus
- positive regulation of protein kinase activity
- positive regulation of protein phosphorylation
- positive regulation of TOR signaling
- protein localization to plasma membrane
- protein phosphorylation
- receptor-mediated virion attachment to host cell
- signal transduction
- symbiont entry into host cell
- viral genome replication
- negative regulation of oligodendrocyte apoptotic process
- negative regulation of renal albumin absorption
Molecular functions
- calcium ion binding
- cysteine-type endopeptidase inhibitor activity involved in apoptotic process
- phosphatidylserine binding
- protein-macromolecule adaptor activity
- receptor ligand activity
- receptor tyrosine kinase binding
- signaling receptor binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- EGF-type aspartate/asparagine hydroxylation site
- Gamma-carboxyglutamic acid-rich (GLA) domain
- EGF-like domain
- Laminin G domain
- EGF-like calcium-binding domain
- Growth factor receptor cysteine-rich domain superfamily
- EGF-like, conserved site
- Concanavalin A-like lectin/glucanase domain superfamily
- Coagulation factor-like, Gla domain superfamily
- EGF-like calcium-binding, conserved site
- Complement Clr-like EGF domain
- Gamma-carboxyglutamic acid-rich (GLA) domain superfamily
- NOTCH1, EGF-like calcium-binding domain
- Growth Arrest-Specific/Sex Hormone-Binding/Vitamin K-Dependent
- Laminin G domain
- Vitamin K-dependent carboxylation/gamma-carboxyglutamic (GLA) domain
- Laminin G domain
- Calcium-binding EGF domain
- Human growth factor-like EGF
- Complement Clr-like EGF-like
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GAS6 as an antibody target. Whether an autoantibody or antibody against GAS6 could matter depends on whether native GAS6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GAS6 is annotated as secreted, so native GAS6 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label GAS6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...